10 Best Performing Dividend ETFs In 2024

3. WisdomTree U.S. LargeCap Dividend Fund (NYSE:DLN)

YTD Share Price Performance as of December 30: 17.63%

WisdomTree U.S. LargeCap Dividend Fund (NYSE:DLN) targets dividend-paying large-cap companies in the US equity market, offering core exposure to this segment. The ETF has an expense ratio of 0.28%, total assets of $4.5 billion, and a 30-day SEC yield of 2.04% as of December 27, 2024. Established on June 16, 2006, it provides a reliable option for dividend-focused investors, which places DLN 3rd on our list of the best performing ETFs.

Pharma powerhouse Johnson & Johnson (NYSE:JNJ) is one of the biggest holdings of WisdomTree U.S. LargeCap Dividend Fund (NYSE:DLN). Johnson & Johnson (NYSE:JNJ) has been entangled in lawsuits over its talc-based baby powder since 1999. These cases, which claim the product causes cancer, have resulted in ongoing legal challenges. A pivotal ruling on the company’s proposed $8 billion settlement is expected from a Houston judge in January 2025. J&J is addressing talc-related lawsuits through a “Texas two-step” strategy, transferring liability to a subsidiary that declares bankruptcy, capping settlement costs at $8 billion. With 83% of claimants supporting the deal, it is likely to gain court approval. If finalized, the settlement could end years of legal battles, boost J&J’s stagnant stock, and refocus the company on growth.

Johnson & Johnson (NYSE:JNJ) delivered strong Q3 results with 6.3% operational sales growth, driven by innovation and high-growth markets. The company achieved FDA approvals, launched new products, and raised its earnings guidance for the third consecutive quarter. Q3 sales reached $22.5 billion, with a net income of $2.7 billion and a quarterly dividend of $1.24 per share.

According to Insider Monkey’s Q3 database, Johnson & Johnson (NYSE:JNJ) was held by 81 hedge funds, up from 80 the previous quarter.